Post

Repare reports data from Phase I solid tumours therapy trial

Repare Therapeutics has reported initial proof of concept monotherapy data from the Phase I MYTHIC Module 1 trial of lunresertib …

Ventyx completes enrolment in ulcerative colitis and plaque psoriasis trials

Ventyx Biosciences has completed the enrolment of patients in the Phase II trial of VTX002 in ulcerative colitis and SERENITY …

VistaGen’s nasal spray could reduce menopausal hot flashes, new data suggests

A neuroactive nasal spray could reduce hot flashes during menopause, according to new data from VistaGen Therapeutics. In a 36-patient Phase …

Study shows WHO’s revised hepatitis B vaccination policy is effective           

The spread of hepatitis B virus (HBV) presents a challenge to global health and is a major contributor to infant …

ASCO 2023: exciting Phase II efficacy data for BMS’ Breyanzi in CLL/SLL

At the American Society of Clinical Oncology (ASCO) Annual Meeting on 2-6 June 2023, results were presented from the Phase …